• Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments pharmaceutical-technology
    August 15, 2017
    Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated, advanced immunotherapies for cancer.
  • Takeda, Shattuck Labs Announce Research Collaboration americanpharmaceuticalreview
    August 11, 2017
    Takeda Pharmaceutical Company and Shattuck Labs announced they have entered into a research collaboration to explore and develop checkpoint fusion proteins,Takeda will hold options for exclusive global development and commercialization rights for up to fo
PharmaSources Customer Service